Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1569
HER2amp
Basal A
Chloroquine
13038.177
uM
11.2470
14.01040
-0.9991 -0.9998 5.0000 0.1931
0.9957
0.9161
HCC1569
HER2amp
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7825.017
uM
13.78420
6.5780
0.2318 0.3003 1.2409 0.1910
0.9602
2.0855
HCC1569
HER2amp
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7824.017
uM
4.64290
6.51640
-0.2086 -0.1820 0.9156 0.3459
0.9706
1.6694
HCC1569
HER2amp
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
9347.017
uM
39.4730
166.61560
-0.1599 -1.0000 0.7629 0.1655
0.9889
1.6249
HCC1569
HER2amp
Basal A
CPT-11
TOP1
TOP
7825.007
uM
inf
81.60280
0.8135 0.5446 3.6135 0.0106
0.5793
1.5199
HCC1569
HER2amp
Basal A
CPT-11
TOP1
TOP
9347.121
uM
25.55240
49.33220
-0.4281 -1.0000 1.6700 0.1014
0.9929
1.4523
HCC1569
HER2amp
Basal A
Dactolisib
PI3K
PI3K
10872.155
uM
0.35934
0.28364
0.3171 0.3468 5.0000 0.2837
0.7323
1.5288
HCC1569
HER2amp
Basal A
Dactolisib
PI3K
PI3K
12523.155
uM
0.56295
0.43605
0.4029 0.3606 5.0000 0.2289
0.8519
1.0583
HCC1569
HER2amp
Basal A
Dichloroacetate
PDK
PDK
13038.176
uM
inf
inf
0.9283 0.9283 0.0000 0.0431
0.2237
1.3069
HCC1569
HER2amp
Basal A
Disulfiram
Proteasome
Proteasome
13038.174
uM
inf
inf
0.7714 0.7714 0.0000 0.2612
0.5075
1.2027
HCC1569
HER2amp
Basal A
Docetaxel
TUBB
TUBB
9347.002
uM
inf
0.00163
0.5098 0.5087 1.2928 0.3277
0.9210
1.4904
HCC1569
HER2amp
Basal A
Docetaxel
TUBB
TUBB
13038.002
uM
0.00570
0.00427
0.1042 0.1775 1.5208 0.4820
0.9830
1.2045
HCC1569
HER2amp
Basal A
Doxorubicin
TOP2
TOP
9347.121
uM
1.05950
1.1610
-0.2489 -0.0990 1.9753 0.3387
0.9752
1.4523
HCC1569
HER2amp
Basal A
Doxorubicin
TOP2
TOP
7825.007
uM
10.52510
19.97490
-0.0130 -0.3301 0.7912 0.1642
0.9812
1.5199
HCC1569
HER2amp
Basal A
Epirubicin
TOP2
TOP
7824.017
uM
0.69563
7.34590
-0.9871 -1.0000 0.4661 0.5315
0.8744
1.6694
HCC1569
HER2amp
Basal A
Epirubicin
TOP2
TOP
9347.017
uM
1.31210
10.00520
-0.9683 -1.0000 0.5408 0.4729
0.9115
1.6249
HCC1569
HER2amp
Basal A
Epirubicin
TOP2
TOP
7825.017
uM
1.60090
11.98260
-0.9503 -1.0000 0.5458 0.4551
0.9163
2.0855
HCC1569
HER2amp
Basal A
Erlotinib
EGFR
ErbB
7447.09
uM
24.60320
146.28430
0.2284 -1.0000 0.6163 0.1574
0.9437
1.5863
HCC1569
HER2amp
Basal A
Erlotinib
EGFR
ErbB
7449.091
uM
20.87780
11.20460
0.3606 0.3331 1.7631 0.0911
0.9914
1.8158
HCC1569
HER2amp
Basal A
Etoposide
TOP2
TOP
7449.074
uM
90.77370
508.07770
0.1261 -1.0000 0.6379 0.1331
0.9895
2.0321
HCC1569
HER2amp
Basal A
Etoposide
TOP2
TOP
7447.074
uM
27.38890
43.41460
0.1521 -0.1436 0.5480 0.2366
0.9905
1.5411
HCC1569
HER2amp
Basal A
Etoposide
TOP2
TOP
7448.074
uM
176.56740
999.88570
0.3682 -0.7709 0.5380 0.1223
0.9905
2.8830
HCC1569
HER2amp
Basal A
Everolimus
MTOR
MTOR
10872.156
uM
0.54271
12.36520
-0.8357 -1.0000 0.3514 0.4642
0.6959
1.5028
HCC1569
HER2amp
Basal A
Everolimus
MTOR
MTOR
12523.164
uM
0.06557
5.9890
-0.7287 -1.0000 0.2434 0.5969
0.7617
0.8230
HCC1569
HER2amp
Basal A
Fascaplysin
CDK4
CDK
7449.084
uM
0.47938
0.82279
-0.8295 -0.8159 1.7913 0.5460
0.9979
2.1410